CoChat

Remote Research and Clinical Trial Integrity During and After the Coronavirus Pandemic

McDermott, Mary M., Newman, Anne B. · 2021 · JAMA
Cited by 104

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Remote Research and Clinical Trial Integrity During and After the Coronavirus PandemicApproximately 1 year ago, in March 2020, clinical trials were suddenly and severely disrupted by the COVID-19 pandemic.Pandemic-related restrictions that limited or prevented in-person visits resulted in unprecedented obstacles to clinical trial enrollment, data collection, and intervention delivery for many clinical trials. 1 As of April 21, 2021, ClinicalTrials.govlisted 1773 suspended clinical trials, with many trials identifying the COVID-19 pandemic as the primary reason for suspension.Ongoing trials that were not suspended are likely to be experiencing challenges with enrollment and fidelity to aspects of study protocols that require in-person contact, including interventions and outcome assessment.Many clinical trial investigators replaced in-person interactions with alternative approaches conducted remotely. 2A survey of 245 clinical trial investigators reported that the proportion of participant interactions conducted remotely increased from 9% in January 2020 to 57% in May 2020. 2 Remote interactions with participants implemented in response to the pandemic included mailings or drop-off of devices, such as physical activity monitors or pulse oximeters for outcome measurements, and mail delivery or drop-off of pills or devices for trial interventions. 3,44][5] These remote activities facilitated clinical trial progress during the pandemic.Embedded trials build data collection for a clinical trial into essential clinical care and represent another alternative to in-person clinical trial interactions.An example is the ongoing Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults (PREVENTABLE) trial (NCT04262206), in which 20 000 participants 75 years or older are randomized to atorvastatin 40 mg daily or placebo and followed up with the electronic health record for outcomes of disability-free survival and cardiovascular events.Medications are mailed to participants' homes.Outcomes that are not part of routine clinical care, including detailed cognitive assessments and physical performance testing, are collected at participants' homes by trained research staff.A visit to a research laboratory is required to collect blood for a biorepository of red blood cells and DNA.An example of a fully remote trial was a randomized, double-blind, clinical trial conducted in St Louis, Missouri, that evaluated whether fluvoxamine, compared with placebo, improved outcomes in 152 outpatients newly diagnosed with COVID-19. 4Eligibility screening was conducted by email and telephone and COVID diagnosis was confirmed using electronic health record

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1001/jama.2021.4609

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 104

Metadata

Authors
McDermott, M. M., & Newman, A. B.
Venue
JAMA
Published
2021-05-18
Volume
325
Issue
19
Pages
1935
ISSN
  • 0002-9955 (ISSN-L)
  • 0098-7484
OpenAlex
W3153321771
Cited by
104
References
3
FWCI
17.97
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.